Gullik Håkan Wickholm
Directeur/Bestuurslid bij Beactica Therapeutics AB
Profiel
Gullik Håkan Wickholm is currently a Director at Beactica Therapeutics AB and GHW Consulting AB.
Previously, he served as the Chief Executive Officer at Lytix Biopharma AS from 2014 to 2017.
He also worked as the Head-Regional Business Development at AstraZeneca.
AS and as a Director at Genovis AB.
Wickholm received his undergraduate degree from the University of Uppsala.
Actieve functies van Gullik Håkan Wickholm
| Bedrijven | Functie | Begin |
|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Directeur/Bestuurslid | 01-01-2018 |
| GHW Consulting AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Gullik Håkan Wickholm
| Bedrijven | Functie | Einde |
|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - |
| GENOVIS AB | Directeur/Bestuurslid | - |
| LYTIX BIOPHARMA | Algemeen Directeur | 07-09-2017 |
Opleiding van Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| GENOVIS AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
